11 Results for "

ACK Inhibitors

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "ACK Inhibitors" in MCE Product Catalog:

6
6 Publications Verification
Cat. No.: HY-13326
CAS No.: 1097917-15-1
Purity:  99.88%
ASP3026 is a selective and orally active inhibitor of anaplastic lymphoma kinase (ALK). ASP3026 is a selective and oral active anaplastic lymphoma kinase (ALK) inhibitor with a IC50 value of 3.5 nM. ASP3026 can inhibit the phosphorylation of IGF-1R, STAT3, AKT and JNK proteins, and induce the cleavage of caspase 3 and PARP. It also inhibited ROS and ACK. ASP3026 can be used in anti-tumor research .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-15290
CAS No.: 873305-35-2
Purity:  99.95%
Target:  

Ack1

Research Areas:  

Cancer

AIM-100 is a potent and selective Ack1 inhibitor with an IC50 of 21.58 nM. AIM-100 also inhibits Tyr 267 phosphorylation. AIM-100 does not inhibits other kinases including PI3-kinase and AKT subfamily members. AIM-100 has an anticancer effect .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-10943
CAS No.: 839706-07-9
Purity:  99.70%
Target:  

Bcr-Abl Ack1

Research Areas:  

Cancer

GNF-7 is a multikinase inhibitor. GNF-7 is a Bcr-Abl inhibitor, with IC50s of 133 nM and 61 nM for Bcr-Abl WT and Bcr-Abl T315I, respectively. GNF-7 also possesses inhibitory activity against both ACK1 (activated CDC42 kinase 1) and GCK (germinal center kinase) with IC50s of 25 nM and 8 nM, respectively. GNF-7 can be used for the research of hematologic malignancies .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-12331
CAS No.: 1472795-20-2
Purity:  96.19%
Research Areas:  

Cancer

KRCA-0008 is a selective ALK/Ack1 inhibitor with IC50s of 12 and 4 nM for ALK and Ack1, respectively. KRCA-0008 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-113787
CAS No.: 1655527-68-6
Purity:  99.51%
Target:  

Ack1 JAK

Research Areas:  

Cancer

(R)-9b is a potent inhibitor of ACK1 tyrosine kinase (IC50=56 nM) with anticancer activity. (R)-9b exhibits selectivity for ACK1 but has inhibitory effects on JAK family kinases JAK2 and Tyk2. (R)-9b can be used in the study of hormone-regulated cancers such as prostate and breast cancer .
loading...
    loading...
Cat. No.: HY-149989
CAS No.: 2924415-92-7
Target:  

Ack1 Akt

Research Areas:  

Cancer

Ack1 inhibitor 1 is a potent, selective, and orally active inhibitor of ACK1 kinase with an IC50 value of 2.1 nM. Ack1 inhibitor 1 inhibits the phosphorylation of ACK1 and activation of downstream AKT. Ack1 inhibitor 1 has anti-tumor activity .
loading...
    loading...
Cat. No.: HY-162254
CAS No.: 3032642-29-5
Target:  

EGFR Ack1

Research Areas:  

Cancer

EGFR T790M/L858R/ACK1-IN-1 is a dual inhibitor of EGFR T790M/L858R and ACK1. IC50 values are 23 and 263 nM, respectively. EGFR T790M/L858R/ACK1-IN-1 can inhibit cell proliferation and has antitumor activity .
loading...
    loading...
Cat. No.: HY-160635
CAS No.: 1196392-26-3
Target:  

Ack1

Research Areas:  

Cancer

Ack1 inhibitor 2 (Example 259) is an Ack1 inhibitor (IC50: 0.46 μM) .
loading...
    loading...
Cat. No.: HY-115828
CAS No.: 1610362-98-5
Target:  

HIV

Research Areas:  

Infection

APA-APA-MPO dihydrochloride is an inhibitor of PCAF bromodomain/Tat-AcK50 interaction with reduced cytotoxic activity. APA-APA-MPO dihydrochloride can effectively inhibit the binding of PCAF to Tat-AcK50, showing its potential in HIV/AIDS inhibitory strategies. APA-APA-MPO dihydrochloride can be used in studies that hinder HIV replication .
loading...
    loading...
Cat. No.: HY-115829
CAS No.: 1610362-93-0
Target:  

HIV

Research Areas:  

Infection

APA-H-MPO hydrochloride is an inhibitor of PCAF bromodomain/Tat-AcK50 interaction with potential for anti-HIV/AIDS. APA-H-MPO hydrochloride can effectively inhibit the binding of PCAF bromodomain to Tat-AcK50. APA-H-MPO hydrochloride showed low cytotoxicity in preliminary cell studies. APA-H-MPO hydrochloride is considered a potential candidate for a promising inhibitory strategy targeting the host cell protein PCAF BRD to block HIV replication .
loading...
    loading...
Cat. No.: HY-13326R
CAS No.: 1097917-15-1
ASP3026 (Standard) is the analytical standard of ASP3026. This product is intended for research and analytical applications. ASP3026 is a selective and orally active inhibitor of anaplastic lymphoma kinase (ALK). ASP3026 is a selective and oral active anaplastic lymphoma kinase (ALK) inhibitor with a IC50 value of 3.5 nM. ASP3026 can inhibit the phosphorylation of IGF-1R, STAT3, AKT and JNK proteins, and induce the cleavage of caspase 3 and PARP. It also inhibited ROS and ACK. ASP3026 can be used in anti-tumor research .
loading...
    loading...
  • 1